Tero Ylisaukko-oja, Author at MedEngine

News Nordic Insights

Unlocking the Nordics: Pharma Strategies That Deliver Impact

Unlocking the Nordics: The Nordic countries may seem like small markets in terms of population, but their importance in pharmaceutical commercialization should not be underestimated.…

Tero Ylisaukko-oja01/10/2025

News Nordic Insights

Key Trends Shaping the Future of Medical Affairs

Over the past decade, medical affairs has undergone a deeper transformation than perhaps any other function in the pharmaceutical industry. What was once viewed as…

Tero Ylisaukko-oja26/08/2025

News Nordic Insights

Turning Real-World Evidence into Real Impact

Generating high-quality real-world evidence (RWE) takes serious effort. Compared to many other activities, it’s quite resource-heavy, time-consuming, and expensive. But too often, teams pour everything…

Tero Ylisaukko-oja03/06/2025

News Nordic Insights

Winning Over Healthcare Professionals in a Noisy Digital World

Let’s be honest: when it comes to digital communication, pharma has historically lagged behind. Winning Over Healthcare Professionals in a Noisy Digital World: While other…

Tero Ylisaukko-oja28/04/2025

News Nordic Insights

Rare Disease Era: Why Pharma’s Playbook Needs a Rewrite

Medicines for rare diseases are no longer a niche category—they’re dominating drug approvals and reshaping the industry. In 2024, over one-third of all EMA positive…

Tero Ylisaukko-oja02/04/2025

News Nordic Insights

The Nordic Opportunity: Turning Real-World Data into a Rare Disease Research Powerhouse

Over the past decade, rare diseases have gone from a niche to a major focus in pharma, thanks to regulatory incentives and advances in precision…

Tero Ylisaukko-oja21/02/2025

News

Saku Torvinen joins MedEngine to launch Market Access services

MedEngine Oy announced today that Saku Torvinen, PhD, joins MedEngine Oy as Director of Market Access. At MedEngine, he will be responsible for the launch…

Tero Ylisaukko-oja11/03/2021

News

MedEngine acquires the Institute of Applied Economics and Health Research ApS (ApHER) to offer Nordic real-world data solutions to global pharmaceutical companies

MedEngine Oy announced today that it has acquired the Institute of Applied Economics and Health Research ApS (ApHER), a leading Danish medical data science company.…

Tero Ylisaukko-oja04/03/2021

In Press

In Press: Vedolizumab may have a real-life corticosteroid sparing effect

Vedolizumab may have a corticosteroid sparing effect in real-world clinical practice, a new Finnish study reveals. The incidence of inflammatory bowel disease (IBD), which include ulcerative colitis…

Tero Ylisaukko-oja15/02/2019

News

BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services

MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, today…

Tero Ylisaukko-oja09/01/2019

Tero Ylisaukko-oja

Recent Posts